Oncomed Manufacturing A.S. (Manufacturing, primary packaging, quality control)

The drug is used for the treatment of malignant unresectable pleural mesothelioma (in combination with cisplatin), as well as non-small cell lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line therapy).

Dosage form: concentrate for infusion solution

ATC: L01BA04